EUROPE/UK - Strong medium-term prospects in biotechs are slowly securing interest from institutional private equity investors, according to new data.
Research from AltAssets predicts more private equity investment in the market but says this time the bubble will not burst as with other previously “hot” venture sectors. According to the firm, ...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
